$HROW 20260116 55.0 CALL$ Come on Harrow... this is an exmaple of how one company stock could badly effected from change of leadership and fearful assumptions In regards to compliance issues/operation disruption/risk of some fine due to compliance issue.
B U T... there is No Confirmed FDA issues and their fundamental is strong despite those noises and speculations.
Personally, I DCA-ed to bring up my negative %(for my premium average cost from Buy-Call option).
Do your due diligence before jump any gun but I foresee Harrow to go above my strike price before this option expiry date...
#harrowhealth #eyecare #optioncall #buycall #trading #option
Comments